FDA Investigator Patrick R Brown
Patrick R Brown has conducted inspections on 74 sites in 1 countries as of 04 May 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
74
Last Inspection Date:
04 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Patrick R Brown:
Aaron J Poloni,
Abby M Miller,
Abigail A Andersen,
Amy R Glynn,
Arie R Dyk,
Beau R Lamb,
Brenda K Alford,
Brian P Hendrickson,
Bryce E Mansfield,
Catherine J Laufmann,
Celia L Hutchinstein,
Celia L Silverstein,
Christina L Norton,
Clint R Van Blaricom,
Crystal A Harlan,
David J Gomes,
David J Hajduk,
Devon M Shoop,
Donald B Mckechnie,
Douglas J Scott,
Elizabeth S Howell,
Emal Wahab,
Eric L Scott,
Erica R Mahone,
Gavin W Pierce,
Harmon M Blanch,
Heika R Tait,
Hugh A Grimoldby,
Ian J Thomson,
James D Hildreth,
James E Trabert,
Jean C Colon Lopez,
Jeannine K Wooten,
Jeff A Gard,
Jeffrey J Leclair,
Jessica B Clark,
Jessica B Zachman,
Jinkee Mvila Binayug,
John E Emmert,
John W Banks,
Jonathan T Little,
Julia E Chervoni,
Julian C Hanson,
Kaitlyn R Kornberg,
Kate L Allen,
Katharine Chan,
Keegan B Mixon,
Kent Widdicombe,
Lenita R Silvera,
Lisa A Bowden,
Lorna F Jones,
Mai Hang,
Margo C Jones,
Maria E Treadwell,
Mark E Imsland,
Michael S Hudson,
Nancy E Doyle,
Neil J Traaen,
Nianna C Burns,
Othello G Capangpangan,
Patrick Brown,
Paul F Rader,
Peter Kessler, PhD,
Peter T Regan,
Rachel J Cantrell,
Rebecca A Sletner,
Richard G Runyon,
Rita E Luttrell,
Rocco C Black,
Roger J Adams,
Ronald E Gill,
Sandra K Wangen,
Scott W Fox,
Shannon J Hall,
Sharon I Gundersen,
Sunny R Muir,
Thomas C Mclean, CFS,
Timothy S Williamson,
Tracy K Li,
William A Burkey,
Zachary P Wachlarowicz,
Zarina M Bestul
Patrick R Brown's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2022 | FDA 483 | American Song - Form 483, 2022-05-24 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more